Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study
Top Cited Papers
- 1 November 2002
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 159 (11) , 1896-1901
- https://doi.org/10.1176/appi.ajp.159.11.1896
Abstract
The authors assessed the efficacy of once-daily atomoxetine administration in the treatment of children and adolescents with attention deficit hyperactivity disorder (ADHD). In a double-blind study, children and adolescents with ADHD (N=171, age range=6-16 years) were randomly assigned to receive 6 weeks of treatment with either atomoxetine (administered once daily) or placebo. Outcomes among atomoxetine-treated patients were superior to those of the placebo treatment group as assessed by investigator, parent, and teacher ratings. The treatment effect size (0.71) was similar to those observed in previous atomoxetine studies that used twice-daily dosing. Parent diary ratings suggested that drug-specific effects were sustained late in the day. Discontinuations due to adverse events were low (less than 3%) for both treatment groups, and no serious safety concerns were observed. Once-daily administration of atomoxetine is an effective treatment for children and adolescents with ADHD.Keywords
This publication has 10 references indexed in Scilit:
- An Open-Label, Dose-Ranging Study of Atomoxetine in Children with Attention Deficit Hyperactivity DisorderJournal of Child and Adolescent Psychopharmacology, 2001
- Validation of the ADHD Rating Scale as a clirlician administered and scored instrumentJournal of Attention Disorders, 2001
- Impairment and Deportment Responses to Different Methylphenidate Doses in Children With ADHD: The MTA Titration TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- The Stimulants RevisitedChild and Adolescent Psychiatric Clinics of North America, 2000
- Effectiveness and Tolerability of Tomoxetine in Adults With Attention Deficit Hyperactivity DisorderAmerican Journal of Psychiatry, 1998
- The Revised Conners' Parent Rating Scale (CPRS-R): Factor Structure, Reliability, and Criterion ValidityJournal of Abnormal Child Psychology, 1998
- Revision and Restandardization of the Conners Teacher Rating Scale (CTRS-R): Factor Structure, Reliability, and Criterion ValidityJournal of Abnormal Child Psychology, 1998
- Bupropion Hydrochloride in Attention Deficit Disorder with HyperactivityJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Clinical significance: A statistical approach to defining meaningful change in psychotherapy research.Journal of Consulting and Clinical Psychology, 1991
- A Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. EfficacyJournal of the American Academy of Child & Adolescent Psychiatry, 1989